Last reviewed · How we verify
FACT Complex-targeting Curaxin CBL0137 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
FACT Complex-targeting Curaxin CBL0137 (FACT Complex-targeting Curaxin CBL0137) — Children's Oncology Group.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| FACT Complex-targeting Curaxin CBL0137 TARGET | FACT Complex-targeting Curaxin CBL0137 | Children's Oncology Group | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- FACT Complex-targeting Curaxin CBL0137 CI watch — RSS
- FACT Complex-targeting Curaxin CBL0137 CI watch — Atom
- FACT Complex-targeting Curaxin CBL0137 CI watch — JSON
- FACT Complex-targeting Curaxin CBL0137 alone — RSS
Cite this brief
Drug Landscape (2026). FACT Complex-targeting Curaxin CBL0137 — Competitive Intelligence Brief. https://druglandscape.com/ci/fact-complex-targeting-curaxin-cbl0137. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab